Recurrent High Grade Ovarian Serous Adenocarcinoma

Also known as: Recurrent Ovarian High Grade Serous Adenocarcinoma

Drug	Drug Name	Drug Description

Drug	Drug Name	Target	Type

Drug	Drug Name	Phase	Status	Count
DB12001	Abemaciclib	1	Recruiting	1
DB00112	Bevacizumab	1	Recruiting	1
DB12218	Capivasertib	1	Recruiting	1
DB09074	Olaparib	1	Completed	1
DB09074	Olaparib	1	Recruiting	1
DB06306	Onalespib	1	Completed	1
DB01229	Paclitaxel	1	Recruiting	1
DB00158	Folic acid	1 / 2	Recruiting	1
DB09037	Pembrolizumab	1 / 2	Recruiting	1
DB04849	Cediranib	2	Active Not Recruiting	1
DB12483	Copanlisib	2	Withdrawn	1
DB00531	Cyclophosphamide	2	Active Not Recruiting	1
DB00997	Doxorubicin	2	Active Not Recruiting	1
DB00997	Doxorubicin	2	Withdrawn	1
DB11714	Durvalumab	2	Active Not Recruiting	1
DB01073	Fludarabine	2	Active Not Recruiting	1
DB14865	Human interleukin-2	2	Active Not Recruiting	1
DB09078	Lenvatinib	2	Recruiting	1
DB17107	Lifileucel	2	Active Not Recruiting	1
DB09074	Olaparib	2	Active Not Recruiting	1
DB09074	Olaparib	2	Withdrawn	1
DB01229	Paclitaxel	2	Active Not Recruiting	1
DB01229	Paclitaxel	2	Withdrawn	1
DB09037	Pembrolizumab	2	Recruiting	1
DB15389	Teceleukin	2	Active Not Recruiting	1
DB00759	Tetracycline	2	Active Not Recruiting	1
DB00759	Tetracycline	2	Withdrawn	1
DB01030	Topotecan	2	Active Not Recruiting	1
DB01030	Topotecan	2	Withdrawn	1